Sign in

NCT07367256Recruiting

Using Virtual Reality to Improve Emotion Understanding in Children With Autism

Efficacy of a Virtual Reality-Mediated Intervention on Emotion Recognition and Understanding in Children With Autism Spectrum Disorder

Source: ClinicalTrials.gov · Last updated 26 Jan 2026

Brief summary (registry, in English)

Autism Spectrum Disorders (ASD) are neurodevelopmental conditions characterized by difficulties in social interaction, communication, and in understanding one's own and others' mental and emotional states. In particular, skills related to the recognition, understanding, and regulation of emotions represent a significant area of vulnerability in children with high-functioning ASD, with important consequences for social and relational functioning. The present study aims to evaluate the effectiveness of an intervention protocol designed to enhance socio-emotional understanding, with a specific focus on the recognition of basic and complex emotions, the expansion of emotional vocabulary, the association between situations, thoughts, and emotions, and the differentiation between thoughts and emotions. Furthermore, the study seeks to investigate the role of immersive technology (Oculus) as a potential facilitator of emotional learning compared to a traditional intervention approach. The sample will consist of children with a diagnosis of high-functioning ASD, aged between 7 and 10 years, with sentence-level language abilities, the capacity to narrate non-present events, and an intellectual quotient above 80 (assessed using the Griffiths Scales or the WISC-IV). Participants will be divided into two groups: an experimental group (OCULUS), which will receive the intervention mediated by the use of Oculus technology, and a control group which will undergo the same protocol without technological support.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
16 Jan 2026
Start date
2 Feb 2026
Primary completion date
30 Jun 2026
Lead sponsor
Istituto per la Ricerca e l'Innovazione Biomedica
Diseases
Autism
NCT number
NCT07367256

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 2 Feb 2026 to the primary completion date, 30 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • presence of other medical disorders

Who the study is looking for

  • Language in sentences
  • Ability to narrate events not present
  • QS/QI\>80

Age in the registry: 7 years to 10 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istituto per la Ricerca e l'Innovazione Biomedica
Coordinator of this site? Confirm its status
MessinaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.